Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print What is the influence of tumor removal on the serum level of carbohydrate's antibody?

What is the influence of tumor removal on the serum level of carbohydrate's antibody?

October 08, 2008

Cancer immune surveillance is considered to be important in the anti-tumor protection of the host. The growing tumor escapes the immune control under the immunosuppressive conditions. The surgical removal of the tumor may reverse the immunosuppression. The TF antigen and Tn belong to tumor-associated carbohydrate antigens (TACA). TF antigen is implicated in the metastatic spread due to the adhesion of cancer cells to the endothelium. However, the dynamic changes of the level of TF and Tn-antibodies in the serum of patients with cancer and its association with survival have been insufficiently studied.

A research article to be published on July 21, 2008 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Kurtenkov from National Institute for Health Development (Tallinn, Estonia) have undertaken a long-term follow-up of cancer patients to determine changes in the postoperative level of TF- and Tn antibodies, as well as to elucidate the association of this level with the progression of cancer, and survival. The level of antibodies in serum was determined by the ELISA using synthetic polyacrylamide (PAA) glycoconjugates.




They found that in gastrointestinal cancer, the TF antibody level was found to have elevated significantly after the removal of G3 tumors as compared with the preoperative level (u = 278.5, P < 0.05). After surgery, the TF and Tn antibody level was elevated in the majority of gastric cancer patients (sign test, 20 vs 8, P < 0.05, and 21 vs 8, P < 0.05, respectively). In gastrointestinal cancer, the elevated postoperative level of TF, Tn and Gal antibodies was noted in most patients with G3 tumors (sign test, 22 vs 5, P < 0.01; 19 vs 6, P < 0.05; 24 vs 8, P < 0.01, respectively), but the elevation was not significant in patients with G1 + G2 resected tumors. The postoperative follow-up showed that the percentage of patients with G3 resected tumors of the digestive tract, who had a mean level of anti-TF IgG above the cutoff value (1.53), was significantly higher than that of patients with G1 + G2 resected tumors (chi2 = 3.89, all patients; chi2 = 5.34, patients without regional lymph node metastases; P < 0.05). The percentage of patients with a tumor in stage I, whose mean anti-TF IgG level remained above the cut-off value (1.26), was significantly higher than that of patients with the cancer in stages II I-IV (chi2 = 4.71, gastric cancer; chi2 = 4.11, gastrointestinal cancer; P < 0.05). The correlation was observed to exist between the level of anti-TF IgG and the count of lymphocytes (r = 0.517, P < 0.01), as well as between the level of anti-Tn IgG and that of serum CA 19-9 (r = 0.481, P < 0.05). No positive delayed-type hypersensitivity reaction in skin test challenges with TF-PAA in any of the fifteen patients, including those with a high level of anti-TF IgG, was observed.

Their result indicated that the surgical operation raises the level of anti-carbohydrate IgG in most patients, especially in those with the G3 tumor of the gastrointestinal tract. The stage and morphology-dependent immuneosuppression affects the TF-antibody response and may be one of the reasons for unresponsiveness to the immunization with TF-antigens.

World Journal of Gastroenterology



Related Immunosuppressive Current Events and Immunosuppressive News Articles Immunosuppressive Current Events and Immunosuppressive News RSS Immunosuppressive Current Events and Immunosuppressive News RSS
Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

Cancer drug effectively treats transplant rejections
University of Cincinnati (UC) researchers have discovered a new therapy for transplant patients, targeting the antibody-producing plasma cells that can cause organ rejection.

What is the mechanism of the chronic radiation enteritis?
The use of radiation therapy to treat cancer inevitably involves exposure of normal tissues.

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

Researcher tricks immune system in diabetic mice
The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it.

Adult stem cell breakthrough
The first tissue-engineered trachea (windpipe), utilising the patient's own stem cells, has been successfully transplanted into a young woman with a failing airway. The bioengineered trachea immediately provided the patient with a normally functioning airway, thereby saving her life.

First Trial in the U.S. to Treat Both Ischemic & Non-Ischemic Heart Failure to be Performed by U of U Researchers Using Patient's Own Stem Cells
Researchers at the University of Utah are enrolling people in a new clinical trial that uses a patient's own stem cells to treat ischemic and non-ischemic heart failure.

African-American Canadians who receive kidney transplants fare better than those in US
African American kidney disease patients in both Canada and the United States are less likely than Caucasian Americans to have access to kidney transplants, but only African-Americans in the United States have worse health outcomes than Caucasians after a transplant is performed.

Study Shows Steroid Therapies Following Transplant Can Be Eliminated
A new study by researchers at UC shows that using modern immunosuppressive drugs eliminates the need for steroid therapy as early as seven days following a transplant surgery while still maintaining kidney function

Mayo Clinic collaborates to advance Crohn's treatment
A study led by Mayo Clinic has found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate to severe Crohn's disease than azathioprine alone.
More Immunosuppressive Current Events and Immunosuppressive News Articles
Immunosuppressives boost cyclosporine's effect: ulcerative colitis.(Clinical Rounds): An article from: Family Practice News
by Jeff Evans

This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2004. The length of the article is 471 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Fewer colectomies: immunosuppressives boost cyclosporine's positive effect on severe ulcerative colitis.(Gastroenterology): An article from: Internal Medicine News
by Jeff Evans

This digital document is an article from Internal Medicine News, published by International Medical News Group on March 1, 2004. The length of the article is 433 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Antineoplastic and Immunosuppressive Agents Part II

Bill eliminating time limit on immunosuppressive drug coverage for kidney recipients introduced in Congress.: An article from: Transplant News
by Jim Warren

This digital document is an article from Transplant News, published by Thomson Gale on August 1, 2007. The length of the article is 922 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Bill...

Recent Developments in Transplantation Medicine: New Immunosuppressive Drugs

Unlimited immunosuppressive drug coverage under Medicare signed into law by President Clinton.(Brief Article): An article from: Transplant News

This digital document is an article from Transplant News, published by Transplant Communications, Inc. on December 29, 2000. The length of the article is 369 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

The Mode of Action of Immunosuppressive Agents. Research Monographs in Immunology, Volume 9
by Jean-Francois Bach, T. B. Strom

Use guidelines to reduce skin Ca risk in transplant patients: immunosuppressive dose reductions.(Dermatologic Therapy): An article from: Skin & Allergy News
by Sharon Worcester

This digital document is an article from Skin & Allergy News, published by International Medical News Group on February 1, 2004. The length of the article is 438 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

Antineoplastic and immunosuppressive agents (Handbook of experimental pharmacology. New series ; 38/1-2)
by Alan C Sartorelli

NKF clarifies who is covered by recent Medicare change to provide unlimited coverage of immunosuppressive drugs.: An article from: Transplant News

This digital document is an article from Transplant News, published by Transplant Communications, Inc. on January 31, 2001. The length of the article is 870 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation...

© 2009 BrightSurf.com